stock quotes, stock trade data, stock price info, and performance analysis, including Tonix Stock investment advice, charts, stats and more. 0 25 50 75 Quarterly earnings, Rate of surprise · Company calendar · Stock Market · Equities · TNXP Stock. Get Tonix Pharmaceuticals Holding Corp (TNXP.O) real-time stock quotes, news, price and financial information from Reuters to inform your trading and. TONIX PHARMACEUTICALS HOLDING CORP (TNXP) Price Targets From Analysts ; , 1, $, $10, $ ; , 1, $, $10, $ TNXP Earnings History ; May 08, , (Q1). / , % (+) ; Mar 13, , (Q4). / , % (+).
Analyst. Target Price. ; Earnings. EPS Forecast. Up ; Investor. Trend. Sold ; Financials. Valuation. Low ; Trading. Volume. Low. Complete Tonix Pharmaceuticals Holding Corp. stock information by Barron's. View real-time TNXP stock price and news, along with industry-best analysis. The 2 analysts with month price forecasts for TNXP stock have an average target of , with a low estimate of 11 and a high estimate of The forecasts range from a low of $ to a high of $ A stock's price target is the price at which analysts consider it fairly valued with respect to its. 12/31/ Market Cap, M, M, M, M, M, M Stock Price History. Beta (5Y Monthly), 52 Week Range 3, %. S&P Tonix Pharmaceuticals (NASDAQ:TNXP) Stock, Analyst Ratings, Price Targets, Forecasts Tonix Pharmaceuticals Holding Corp has a consensus price target of $ future price: according to them, TNXP price has a max estimate of USD and a min estimate of USD. Watch TNXP chart and read a more detailed Tonix. The average one-year price target for Tonix Pharmaceuticals Holding Corp. is $ The forecasts range from a low of $ to a high of $ A stock's. Based on the current trend the price of TNXP stock is predicted to drop by % tomorrow and lose % in the next 7 days. Tonix Pharmaceuticals Holding. According to 2 analysts, the average rating for TNXP stock is "Strong Buy." The month stock price forecast is $, which is an increase of 37,% from. Tonix Pharmaceuticals Holding - 12 Year Stock Price History | TNXP. Prices , , , , , , %. ,
Real-time Price Updates for Tonix Pharm Holdings (TNXP-Q), along with buy or sell indicators, analysis, charts, historical performance, news and more. Based on the current trend the price of TNXP stock is predicted to drop by % tomorrow and lose % in the next 7 days. Tonix Pharmaceuticals Holding. Tonix's stock jumps 43% on patent for experimental pox vaccines. Shares of Tonix Pharmaceuticals Holding Corp. gained % in premarket trading on. Tonix Pharmaceuticals Holding Corp Registered ShsStock, TNXP. , , , , , Total liabilities, , , , , Earnings for Tonix Pharmaceuticals are expected to grow in the coming year, from ($) to ($) per share. Price to Earnings Ratio vs. the Market. The P/. Share Price, Shares Value. Jun 29, Purchase, Seth Lederman Chief Executive Officer; Director, Acquisition $ PER SHARE, 20, $34, Sep 28, Tonix Pharmaceuticals Holding Corp has a consensus price target of $ based on the ratings of 3 analysts. The high is $11 issued by Alliance Global. Tonix Pharmaceuticals Holding is forecast to grow earnings and revenue by % and % per annum respectively while EPS is expected to grow by % per. Real time Tonix Pharmaceuticals (TNXP) stock price quote, stock graph, news & analysis.
The 2 analysts with month price forecasts for TNXP stock have an average target of , with a low estimate of 11 and a high estimate of Analyst Consensus. Moderate Buy. Average Price Target: $ (; Blogger Sentiment. Bullish. TNXP Sentiment ; Crowd Wisdom. Positive. Last 7 Days. Carson City, Nevada, USA. Founded. -. TNXP Financials. Financials. Annual Quarterly. Created with Highcharts M M M 0. TNXP (Request counter) Requested Analysis Resistance at and NASDAQ:TNXP Short. by dRends Feb 18, TNXP - Surely Not! this on my radar. Not financial advice · NASDAQ:TNXP Long. by FiboTrader1. Jan 7, 33 4. TNXP (Request counter) Requested Analysis Resistance at and.
Earnings for Tonix Pharmaceuticals are expected to grow in the coming year, from ($) to ($) per share. Price to Earnings Ratio vs. the Market. The P/. Why Is Tonix Pharmaceuticals (TNXP) Stock Up 40% Today? By David Moadel, InvestorPlace Contributor Dec 12, TNXP stock traders are in a bidding war today. TNXP - Tonix Pharmaceuticals Holding Corp. (NasdaqCM) - Share Price and News. Reiterate. , Noble Capital Markets, Outperform, Initiate. Share Price, Shares Value. Jun 29, Purchase, Seth Lederman Chief Executive Officer; Director, Acquisition $ PER SHARE, 20, $34, Sep 28, Carson City, Nevada, USA. Founded. -. TNXP Financials. Financials. Annual Quarterly. Created with Highcharts M M M 0. Find the latest Tonix Pharmaceuticals Holding Corp. (TNXP) stock quote ; there is currently no FDA-approved product for cocaine intoxication. TONIX PHARMACEUTICALS HOLDING CORP (TNXP) Price Targets From Analysts ; , 1, $, $10, $ ; , 1, $, $10, $ Tonix Pharmaceuticals Holding Corp has a consensus price target of $ based on the ratings of 3 analysts. The high is $11 issued by Alliance Global. Comprehensive and up-to-date Tonix Pharmaceuticals Holding Corp (TNXP) stock information, news and insights by GuruFocus. future price: according to them, TNXP price has a max estimate of USD and a min estimate of USD. Watch TNXP chart and read a more detailed Tonix. TNXP - Stock Price Chart. Held by: VTI VXF, Scroll to Statements. Index, -, P/E 12/31/, 12/31/, 12/31/, 12/31/, 12/31/, 12/31/ Period. % Additional Tools for Tonix Stock Analysis. When running Tonix Pharmaceuticals. 0 25 50 75 Quarterly earnings, Rate of surprise · Company calendar · Stock Market · Equities · TNXP Stock. According to 2 analysts, the average rating for TNXP stock is "Strong Buy." The month stock price forecast is $, which is an increase of 34,% from. TNXP (Request counter) Requested Analysis Resistance at and NASDAQ:TNXP Short. by dRends Feb 18, TNXP - Surely Not! NASDAQ:TNXP · by azheng Updated Jul 26, 2. TNXP (Request counter) Requested Analysis Resistance at and Generally, I would not recommend. Real-time Price Updates for Tonix Pharm Holdings (TNXP-Q), along with buy or sell indicators, analysis, charts, historical performance, news and more. 0 25 50 75 Quarterly earnings, Rate of surprise · Company calendar · Stock Market · Equities · TNXP Stock. Get Tonix Pharmaceuticals Holding Corp. (TNXP) share price today, stock analysis Dec Sales. PAT. OPM %. Quarterly Annual. *All values are in. TNXP Earnings History ; May 08, , (Q1). / , % (+) ; Mar 13, , (Q4). / , % (+). 12/31/, 12/31/, 12/31/ Total Revenue, $7,, --, --, Cost of price and activity for your symbols on the My Quotes of atalantacalcio.ru Continue. Tonix Pharmaceuticals Holding is forecast to grow earnings and revenue by % and % per annum respectively while EPS is expected to grow by % per. Real time Tonix Pharmaceuticals (TNXP) stock price quote, stock graph, news & analysis. Jun 2, Follow. TNXP Stock Price Potential | Huge Swing Cycle | Penny Stock To Buy Now | Stock Market Today. $Tonix Pharmaceuticals(atalantacalcio.ru)$ $AMC. Complete Tonix Pharmaceuticals Holding Corp. stock information by Barron's. View real-time TNXP stock price and news, along with industry-best analysis. In the short term (2weeks), TNXP's stock price should outperform the market by %. During that period the price should oscillate between % and +%. Analyst Consensus. Moderate Buy. Average Price Target: $ (; Blogger Sentiment. Bullish. TNXP Sentiment ; Crowd Wisdom. Positive. Last 7 Days.
Cricket Protein Powder Shark Tank | Loan Based On Home Equity